Trial Profile
A Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Investigate the Effects of SB-742457, Donepezil and Placebo on Cognition in Subjects With Mild to Moderate Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Intepirdine (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GlaxoSmithKline Research & Development; GSK
- 01 Jun 2019 Trial has been completed in UK according to European Clinical Trials Database record.
- 31 Jul 2008 Results were presented at the 12th International Conference on Alzheimer's Disease and Related Disorders.
- 09 Apr 2008 Status change from in progress to completed, as reported by clinialtrials.gov.